BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22229256)

  • 1. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial.
    Badawy AM; Elnashar AM; Mosbah AA
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):489-95. PubMed ID: 22229256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study.
    Lossl K; Loft A; Freiesleben NL; Bangsbøll S; Andersen CY; Pedersen AT; Hartwell D; Andersen AN
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):48-53. PubMed ID: 19261371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist.
    Kimura F; Takahashi K; Takebayashi K; Fujiwara M; Kita N; Noda Y; Harada N
    Fertil Steril; 2007 Jun; 87(6):1468.e9-12. PubMed ID: 17222833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
    Verma A; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):112-5. PubMed ID: 19233536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gonadotropin releasing hormone agonists in the treatment of adenomyosis with infertility].
    Lin J; Sun C; Li R
    Zhonghua Fu Chan Ke Za Zhi; 1999 Apr; 34(4):214-6. PubMed ID: 11326917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
    Vilos AG; Oraif A; Machado M; Abu-Rafea B; Vilos GA
    J Obstet Gynaecol Can; 2019 Jun; 41(6):772-781. PubMed ID: 30413336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis.
    Alborzi S; Hamedi B; Omidvar A; Dehbashi S; Alborzi S; Alborzi M
    Arch Gynecol Obstet; 2011 Jul; 284(1):105-10. PubMed ID: 20661580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.
    Ferrero S; Gillott DJ; Venturini PL; Remorgida V
    Reprod Biol Endocrinol; 2011 Jun; 9():89. PubMed ID: 21693038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
    Duhan N; Madaan S; Sen J
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial.
    Ferrero S; Venturini PL; Gillott DJ; Remorgida V
    Reprod Biol Endocrinol; 2011 Jun; 9():88. PubMed ID: 21693037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
    Zhou H; Cao D; Yang J; Shen K; Lang J
    Int J Gynecol Cancer; 2017 Jul; 27(6):1178-1182. PubMed ID: 28562472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
    Sharma S; RoyChoudhury S; Bhattacharya MP; Hazra S; Majhi AK; Oswal KC; Chattopadhyay R
    Reprod Biomed Online; 2023 Jul; 47(1):84-93. PubMed ID: 37149412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goserelin plus letrozole as first- or second-line hormonal treatment in premenopausal patients with advanced breast cancer.
    Yao S; Xu B; Li Q; Zhang P; Yuan P; Wang J; Ma F; Fan Y
    Endocr J; 2011; 58(6):509-16. PubMed ID: 21532215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
    Manetta LA; de Paula Martins W; Rosa e Silva JC; de Sá Rosa e Silva AC; Nogueira AA; Ferriani RA
    Ultrasound Med Biol; 2008 Dec; 34(12):1914-8. PubMed ID: 18597921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors for uterine fibroids.
    Song H; Lu D; Navaratnam K; Shi G
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility.
    Lin J; Sun C; Zheng H
    Chin Med J (Engl); 2000 May; 113(5):442-5. PubMed ID: 11776101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.